Landmark Bio today announced it has been acquired by Artis BioSolutions ("Artis"), a newly launched company dedicated to streamlining the discovery, process development, and manufacturing of genetic ...
Accenture, Deloitte, IBM and other firms submitted proposed price concessions but are expected to be asked to dig deeper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback